Russell Investments Group Ltd. increased its position in shares of Chemed Corp. (NYSE:CHE) by 9.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 159,782 shares of the company’s stock after buying an additional 14,071 shares during the period. Russell Investments Group Ltd. owned 1.00% of Chemed Corp. worth $32,285,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of CHE. Voya Investment Management LLC boosted its holdings in shares of Chemed Corp. by 39.7% during the 2nd quarter. Voya Investment Management LLC now owns 214,764 shares of the company’s stock worth $43,926,000 after buying an additional 61,056 shares during the period. Old Mutual Global Investors UK Ltd. boosted its holdings in shares of Chemed Corp. by 173.5% during the 3rd quarter. Old Mutual Global Investors UK Ltd. now owns 95,212 shares of the company’s stock worth $19,237,000 after buying an additional 60,399 shares during the period. Renaissance Technologies LLC boosted its holdings in shares of Chemed Corp. by 248.5% during the 2nd quarter. Renaissance Technologies LLC now owns 70,400 shares of the company’s stock worth $14,399,000 after buying an additional 50,200 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Chemed Corp. by 1.9% during the 2nd quarter. Vanguard Group Inc. now owns 1,830,711 shares of the company’s stock worth $374,435,000 after buying an additional 34,938 shares during the period. Finally, AJO LP boosted its holdings in shares of Chemed Corp. by 49.6% during the 2nd quarter. AJO LP now owns 94,123 shares of the company’s stock worth $19,251,000 after buying an additional 31,200 shares during the period. 96.50% of the stock is owned by institutional investors and hedge funds.
Several analysts recently issued reports on the stock. Oppenheimer Holdings, Inc. upped their price objective on shares of Chemed Corp. from $220.00 to $225.00 and gave the stock an “outperform” rating in a report on Friday, October 27th. National Bank Financial upgraded shares of Chemed Corp. from a “sector perform market weight” rating to an “outperform market weight” rating in a research note on Sunday, August 13th. Zacks Investment Research cut shares of Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Wednesday, September 13th. BidaskClub cut shares of Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Wednesday, August 2nd. Finally, Royal Bank Of Canada reiterated a “hold” rating and set a $209.00 target price on shares of Chemed Corp. in a research note on Monday, July 31st. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $236.00.
WARNING: This piece was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international trademark and copyright law. The legal version of this piece can be read at https://ledgergazette.com/2017/11/22/chemed-corp-che-position-increased-by-russell-investments-group-ltd.html.
In other news, VP Michael D. Witzeman sold 1,579 shares of the stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $235.00, for a total value of $371,065.00. Following the completion of the transaction, the vice president now owns 4,334 shares in the company, valued at approximately $1,018,490. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Spencer S. Lee sold 1,000 shares of the stock in a transaction on Friday, September 1st. The shares were sold at an average price of $197.46, for a total transaction of $197,460.00. Following the completion of the transaction, the insider now owns 37,809 shares of the company’s stock, valued at approximately $7,465,765.14. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,229 shares of company stock valued at $7,556,478. Corporate insiders own 4.90% of the company’s stock.
Chemed Corp. (NYSE CHE) opened at $238.14 on Wednesday. The company has a market cap of $3,697.73, a price-to-earnings ratio of 28.52, a P/E/G ratio of 4.90 and a beta of 1.14. Chemed Corp. has a one year low of $145.35 and a one year high of $238.40. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.48 and a current ratio of 0.50.
Chemed Corp. (NYSE:CHE) last released its earnings results on Thursday, October 26th. The company reported $2.15 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.00 by $0.15. The firm had revenue of $417.40 million during the quarter, compared to analysts’ expectations of $414.34 million. Chemed Corp. had a net margin of 4.62% and a return on equity of 27.69%. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.73 EPS. equities analysts predict that Chemed Corp. will post 4.73 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, December 4th. Investors of record on Monday, November 13th will be paid a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a yield of 0.47%. The ex-dividend date is Friday, November 10th. Chemed Corp.’s payout ratio is currently 24.89%.
About Chemed Corp.
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corp. (NYSE:CHE).
Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.